Physiology of non-invasive respiratory support

• Published in: Seminars in fetal & neonatal medicine 2016-06, Vol.21 (3), p.174-180
• Main Authors: Alexiou, Stamatia, Panitch, Howard B
• Format: Article
• Language: English
• Subjects: Continuous Positive Airway Pressure - methods; Humans; Infant, Newborn; Infant, Premature; Lung - physiopathology; Lung mechanics; Nasal continuous positive airway pressure; Neonatal and Perinatal Medicine; Prematurity; Respiratory distress syndrome; Respiratory Distress Syndrome, Newborn - physiopathology; Respiratory Distress Syndrome, Newborn - therapy; Respiratory Function Tests
• ISSN: 1744-165X; 1878-0946
• DOI: 10.1016/j.siny.2016.02.007

Summary Non-invasive ventilation (NIV) is used in neonates to treat extrathoracic and intrathoracic airway obstruction, parenchymal lung disease and disorders of control of breathing. Avoidance of airway intubation is associated with a reduction in the incidence of chronic lung disease among preterm infants with respiratory distress syndrome. Use of nasal continuous positive airway pressure (nCPAP) may help establish and maintain functional residual capacity (FRC), decrease respiratory work, and improve gas exchange. Other modes of non-invasive ventilation, which include heated humidified high-flow nasal cannula therapy (HHHFNC), nasal intermittent mandatory ventilation (NIMV), non-invasive pressure support ventilation (NI-PSV), and bi-level CPAP (SiPAP™), have also been shown to provide additional benefit in improving breathing patterns, reducing work of breathing, and increasing gas exchange when compared with nCPAP. Newer modes, such as neurally adjusted ventilatory assist (NAVA), hold the promise of improving patient–ventilator synchrony and so might ultimately improve outcomes for preterm infants with respiratory distress.